TrialNature communications2026

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.